EWM
VRTX icon

Empirical Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Empirical Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Sell
414
-245
-37% -$109K ﹤0.01% 1008
2026
Q1 		$294K Sell
659
-1,172
-64% -$546K 0.01% 797
2025
Q4 		$830K Buy
1,831
+156
+9% +$67.2K 0.01% 371
2025
Q3 		$656K Sell
1,675
-377
-18% -$158K 0.01% 402
2025
Q2 		$914K Buy
2,052
+215
+12% +$99.1K 0.02% 322
2025
Q1 		$891K Buy
1,837
+1,146
+166% +$534K 0.02% 312
2024
Q4 		$278K Sell
691
-153
-18% -$70.9K 0.01% 518
2024
Q3 		$393K Sell
844
-3
-0.4% -$1.44K 0.01% 418
2024
Q2 		$397K Sell
847
-404
-32% -$175K 0.01% 400
2024
Q1 		$523K Buy
1,251
+203
+19% +$85.8K 0.02% 334
2023
Q4 		$426K Buy
1,048
+68
+7% +$25.1K 0.01% 344
2023
Q3 		$341K Sell
980
-21
-2% -$7.34K 0.01% 351
2023
Q2 		$352K Sell
1,001
-345
-26% -$116K 0.01% 352
2023
Q1 		$424K Hold
1,346
– – 0.02% 348
2022
Q4 		$389K Sell
1,346
-39
-3% -$11.9K 0.02% 348
2022
Q3 		$401K Sell
1,385
-393
-22% -$113K 0.02% 332
2022
Q2 		$501K Sell
1,778
-307
-15% -$82.2K 0.03% 294
2022
Q1 		$544K Sell
2,085
-1,815
-47% -$431K 0.03% 316
2021
Q4 		$856K Sell
3,900
-2,072
-35% -$403K 0.04% 243
2021
Q3 		$1.08M Buy
5,972
+2,031
+52% +$397K 0.06% 180
2021
Q2 		$795K Buy
3,941
+1,529
+63% +$320K 0.05% 219
2021
Q1 		$518K Buy
+2,412
New +$530K 0.04% 243

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Empirical Wealth Management's VRTX Position: Q2 2026 in Review

Empirical Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 37% in Q2 2026, selling an estimated $109K and leaving 414 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #1008.

Empirical Wealth Management first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.08M in Q3 2021. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Empirical Wealth Management held 414 shares of Vertex Pharmaceuticals worth $206K as of Q2 2026.
  • Empirical Wealth Management sold 245 Vertex Pharmaceuticals shares in Q2 2026, an estimated $109K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #1008 holding.
  • Empirical Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Empirical Wealth Management's Vertex Pharmaceuticals position peaked at $1.08M in Q3 2021.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.